Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuwe richtlijn screenen op aneurysmata
mrt 2023 | Chronische nierschade, Neuro-vasculair